Patent details

EP3585382 Title: USE OF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Basic Information

Publication number:
EP3585382
PCT Application Number:
GB2018053590
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP188193650
PCT Publication Number:
WO2019116021
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
French Title of Invention:
UTILISATION DE 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE POUR LE TRAITEMENT D'EXACERBATIONS AIGUËS D'UNE MALADIE PULMONAIRE OBSTRUCTIVE CHRONIQUE
German Title of Invention:
VERWENDUNG VON 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMID ZUR BEHANDLUNG VON AKUTER VERSCHLIMMERUNG VON CHRONISCH OBSTRUKTIVER ATEMWEGSERKRANKUNG
SPC Number:

Dates

Filing date:
11/12/2018
Grant date:
14/07/2021
EP Publication Date:
01/01/2020
PCT Publication Date:
20/06/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/07/2021
EP B1 Publication Date:
14/07/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
11/12/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/07/2021
 
 

Name:
Mereo BioPharma 1 Limited
Address:
1 Cavendish Place, London, Greater London W1G 0QF, United Kingdom (GB)

Inventor

1

Name:
MACKINNON, Alastair
Address:
United Kingdom (GB)

2

Name:
PARKIN, Jacqueline
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201720622
Priority Date:
11/12/2017
Priority Country:
United Kingdom (GB)

2

Priority Number:
201802354
Priority Date:
13/02/2018
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 31/415; A61P 11/00;

Publication

European Patent Bulletin

Issue number:
202128
Publication date:
14/07/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/06/2026
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
28/11/2024
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages